Skip to main content
. 2019 Oct 3;11(10):510. doi: 10.3390/pharmaceutics11100510

Table 1.

Overview of the groups and formulations used for the in vivo study.

Group Formulation Day 0 Week 3
A Pre-F core-shell implant Pre-F core-shell implant -
B Pre-F-PBS + pre-F core-shell implant Pre-F-PBS + pre-F core-shell implant -
C Pre-F-PBS Pre-F-PBS -
D Placebo core-shell implant Placebo core-shell implant -
E PBS (- control) PBS PBS